comprehensive -WSS

comprehensive

author：explore 2025-10-02 20:53:03 - browse：169

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Data don't support strong claims for Covid

hotspot

WSS

Illumina board agrees to spin off Grail, as divestment plans proceed

Testing for cancer recurrence creates a new limbo for patients

How CO2 helps viruses stay alive longer in the air

BD to buy Edwards patient monitoring unit for $4.2 billion

Medtronic CEO on promising devices for diabetes, hypertension

Senators tussle over abortion against the backdrop of a presidential campaign

explore

comprehensive

leisure time

Medicare details structure of new drug price negotiation program

Stopping antidepressants leads to symptoms for 1 in 6 patients

Wildfire smoke exposes gaps in outdoor worker protections

Chimpanzees, like humans and whales, get menopause: Study

Sports medicine is finally prioritizing gender equality

Readout Newsletter: XBI biotech index, Akero Therapeutics

United colonoscopy coverage change 'may cost lives,' doctors say

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

United colonoscopy coverage change 'may cost lives,' doctors say

The most pressing bird flu mysteries scientists want answered

hotspot

Traditional Chinese medicine benefits explored in new JAMA study

ASCO Daily Recap: CAR

Finland to offer bird flu vaccine to select groups of people, a possible global first

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

FDA approves Moderna’s RSV vaccine, its second licensed product

leisure time

hotspot

focus

leisure time